1. Home
  2. VATE vs VNRX Comparison

VATE vs VNRX Comparison

Compare VATE & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VATE
  • VNRX
  • Stock Information
  • Founded
  • VATE 1994
  • VNRX N/A
  • Country
  • VATE United States
  • VNRX United States
  • Employees
  • VATE N/A
  • VNRX N/A
  • Industry
  • VATE Metal Fabrications
  • VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • VATE Industrials
  • VNRX Health Care
  • Exchange
  • VATE Nasdaq
  • VNRX Nasdaq
  • Market Cap
  • VATE 65.1M
  • VNRX 64.8M
  • IPO Year
  • VATE 1996
  • VNRX N/A
  • Fundamental
  • Price
  • VATE $5.69
  • VNRX $0.60
  • Analyst Decision
  • VATE
  • VNRX Strong Buy
  • Analyst Count
  • VATE 0
  • VNRX 4
  • Target Price
  • VATE N/A
  • VNRX $3.50
  • AVG Volume (30 Days)
  • VATE 22.6K
  • VNRX 196.8K
  • Earning Date
  • VATE 11-05-2025
  • VNRX 08-14-2025
  • Dividend Yield
  • VATE N/A
  • VNRX N/A
  • EPS Growth
  • VATE N/A
  • VNRX N/A
  • EPS
  • VATE N/A
  • VNRX N/A
  • Revenue
  • VATE $995,000,000.00
  • VNRX $1,319,252.00
  • Revenue This Year
  • VATE N/A
  • VNRX $274.46
  • Revenue Next Year
  • VATE N/A
  • VNRX $212.60
  • P/E Ratio
  • VATE N/A
  • VNRX N/A
  • Revenue Growth
  • VATE N/A
  • VNRX 35.10
  • 52 Week Low
  • VATE $3.25
  • VNRX $0.40
  • 52 Week High
  • VATE $13.79
  • VNRX $0.94
  • Technical
  • Relative Strength Index (RSI)
  • VATE 58.49
  • VNRX 39.24
  • Support Level
  • VATE $4.98
  • VNRX $0.64
  • Resistance Level
  • VATE $5.72
  • VNRX $0.73
  • Average True Range (ATR)
  • VATE 0.39
  • VNRX 0.04
  • MACD
  • VATE 0.11
  • VNRX -0.00
  • Stochastic Oscillator
  • VATE 97.27
  • VNRX 19.34

About VATE INNOVATE Corp.

Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: